- Category
- Micro (2020-21)
- Udyam number
- UDYAM-UP-66-0000157

Sparse Pharma Private Limited
About Sparse Pharma Private Limited
Data last updated:
Sparse Pharma Private Limited is a private limited company based in Bhadohi, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 22 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24290UP2020PTC128713.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Priyanka Mishra and Reena Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khemhaipur Asnaw Bazar, Bhadohi, Uttar Pradesh, India – 221401.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.95 Lakh, a decline of 39% compared to the previous year. For the same year it recorded a net profit of ₹7,205 (net margin 1%) and EBITDA of ₹22,733 (EBITDA margin 3.3%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years.
Sparse Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-66-0000157).
Company details
Recognitions & Rankings of Sparse Pharma
Contact details
Sparse Pharma Private Limited's registered office is in Bhadohi, Uttar Pradesh.
- Registered AddressKhemhaipur Asnaw Bazar, Bhadohi, Uttar Pradesh, India – 221401
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sparse Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sparse Pharma Private Limited, buy the company report.
Financials of Sparse Pharma Private Limited
FY 2025 filings availableSparse Pharma Private Limited reported revenue of ₹6.95 Lakh (down 39% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 12% over three years, including a 39% fall in the latest year. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22,733 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7,205 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sparse Pharma Private Limited, buy the company report.
Board of directors of Sparse Pharma Private Limited
Sparse Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Mishra Also directs: Spradda Pharmaceutical LLP | Director | 19 Nov 2020 | 6 Years 0 Months | Current |
| Reena Devi | Director | 22 May 2020 | 6 Years 5 Months | Current |
Peer comparison
Sparse Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anoya Naturals Private Limited | ₹6.99 Lakh (FY 2025) | 4.0% | Hyderabad, Telangana, India | |||
| Leukman Biotech Private Limited | ₹6.99 Lakh (FY 2024) | 318.0% | Hyderabad, Telangana, India | |||
| Danve Industries Private Limited | ₹6.99 Lakh (FY 2020) | 226.0% | Pune, Maharashtra, India | |||
| Rxsum Pharmaceuticals Private Limited | ₹6.98 Lakh (FY 2017) | Jaipur, Rajasthan, India | ||||
| Bedi Mehandi Udyog Private Limited | ₹6.96 Lakh (FY 2024) | Sri Ganganagar, Rajasthan, India | ||||
| Sparse Pharma Private Limitedthis company | ₹6.95 Lakh (FY 2025) | ₹7,205 | 1% | -39.0% | Bhadohi, Uttar Pradesh, India | |
| Shraddha Resins & Chemicals Private Limited | ₹6.95 Lakh (FY 2016) | -90.0% | Kolkata, West Bengal, India | |||
| Urvashi Chemicals Pvt Ltd | ₹6.95 Lakh (FY 2025) | -21.0% | Ankleshwar, Gujarat, India | |||
| Nuvohelix Bioinnovations Private Limited | ₹6.94 Lakh (FY 2025) | 71.0% | Bangalore, Karnataka, India | |||
| Ernesta Healthcare Private Limited | ₹6.94 Lakh (FY 2021) | 1.0% | Vasai West, Maharashtra, India | |||
| Dharma Ventures Private Limited | ₹6.92 Lakh (FY 2025) | 396.0% | New Delhi, Delhi, India |
To see the full peer comparison of Sparse Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sparse Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sparse Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sparse Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sparse Pharma Private Limited has 5 board changes on record since 2020: 2 appointments and 3 cessations. The latest: Ravishankar Mishra ceased to be Director on 01 Sep 2021.
Frequently asked questions
Sparse Pharma is an active private limited company based in Bhadohi, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 22 May 2020 (6+ years old) and is registered under CIN U24290UP2020PTC128713.
Sparse Pharma has 2 current directors:
- Priyanka Mishra - Director
- Reena Devi - Director
The latest financial statements of Sparse Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Sparse Pharma is U24290UP2020PTC128713. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sparse Pharma was incorporated on 22 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Sparse Pharma by revenue are Anoya Naturals Private Limited, Leukman Biotech Private Limited, Danve Industries Private Limited, Rxsum Pharmaceuticals Private Limited, Bedi Mehandi Udyog Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ravishankar Mishra ceased to be Director on 01 Sep 2021. Neeraj Kumar Dubey ceased to be Director on 19 Nov 2020. Priyanka Mishra was appointed as Director on 19 Nov 2020. Sparse Pharma has 5 board changes on record in total.
Yes, Sparse Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-66-0000157).
The registered office of Sparse Pharma is at Khemhaipur Asnaw Bazar, Bhadohi, Uttar Pradesh, India – 221401.
Sparse Pharma operates in the chemicals industry, in the manufacturing segment.
Sparse Pharma can be reached at its registered office: Khemhaipur Asnaw Bazar, Bhadohi, Uttar Pradesh, India – 221401.

